What is Prestige Consumer Healthcare's market cap?

Prestige Consumer Healthcare (PBH) has a market capitalization of $2.4B and trades on NYSE.

What is Prestige Consumer Healthcare's revenue and profitability?

Prestige Consumer Healthcare generated $1.1B in trailing twelve-month revenue with net income of $190.3M, representing a net margin of 17.5%. Gross margin stands at 54.7%, with free cash flow of $246.4M. These figures are based on the Q1 2026 filing.

Who are Prestige Consumer Healthcare's competitors?

Prestige Consumer Healthcare's key competitors include Perrigo Company, Procter & Gamble, Johnson & Johnson, and others. These companies compete in similar markets and product categories.

Who does Prestige Consumer Healthcare partner with?

Prestige Consumer Healthcare's notable partners include Information Resources, Inc., Amazon, Walmart.

Where is Prestige Consumer Healthcare headquartered?

Prestige Consumer Healthcare is headquartered in United States of America and employs approximately 570 people. It has been publicly traded since 2005.

Prestige Consumer Healthcare

PBH

Prestige Consumer Healthcare is a leading developer and distributor of over-the-counter (OTC) health and personal care products.

Market cap

$2.39B-35.5%

Revenue$1.1B-4.3%

Net income$190.3M-11.3%

Free cash flow$246.4M+1.3%

EPS (diluted)$3.91-9.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q4 2026 report

May 13, 2026

Revenue$281.6MMiss by $12.0M EPS$1.23Miss by $0.16

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$249.7M

EPS estimate$0.89

Financials

Q4 2026

Income statement

See full

Revenue$281.6M-5.0%

Gross profit$146.3M-13.9%

Operating income$75.5M-14.6%

Net income$53.9M+7.6%

EPS (diluted)$1.13+11.9%

Balance sheet

See full

Cash & equivalents$63.9M-34.8%

Total debt$1.0B-0.2%

Total equity$1.9B+2.9%

Total assets$3.5B+2.7%

Cash flow

See full

Operating cash flow$42.8M-30.7%

CapEx$5.2M+49.8%

Free cash flow$37.6M-35.5%

Valuation & ratios

Valuation

See full

Market cap$2.39B-35.5%

Enterprise value$3.37B-27.7%

P/E12.6×-5.1×

P/S2.2×-1.2×

Profitability

See full

Gross margin54.7%-1.1pp

Operating margin28.4%-1.2pp

Net margin17.5%-1.4pp

FCF margin22.6%+1.3pp

Returns & leverage

See full

Return on equity10.2%-2.1pp

Debt / equity0.6×0.0×

Current ratio3.6×-0.6×

Segments

By product

See full

Gastrointestinal$68.4M-0.8%

Women's Health$57.0M-10.6%

Eye & Ear Care$37.9M-19.0%

Dermatologicals$30.5M+4.8%

Analgesics$28.2M-6.5%

By segment

See full

North American OTC Healthcare$234.5M-5.8%

International OTC Healthcare$47.1M-1.0%

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

Procter & Gamble$346.10B-6.0%

Cencora$60.5B+9.1%

PBH

Prestige Consumer Healthcare$2.4B-36.4%

Perrigo Company$1.4B-63.7%

HRO

Harrow$1.4B+9.1%

PetMed Express$42.1M-42.6%

NexGel, Inc.$4.0M-76.9%

By revenue growth

HRO

Harrow+26.2%

Johnson & Johnson+8.1%

Cencora+5.9%

Procter & Gamble+3.3%

Perrigo Company-3.6%

PBH

Prestige Consumer Healthcare-4.3%

By net margin

Johnson & Johnson21.48%-3.5pp

Procter & Gamble19.16%+0.7pp

PBH

Prestige Consumer Healthcare17.48%-1.4pp

Cencora0.599%+0.6pp

HRO

Harrow-19.75%+1.0pp

Perrigo Company-43.5%-39.3pp

Profile

Prestige Consumer Healthcare is a leading developer and distributor of over-the-counter (OTC) health and personal care products. The company focuses on acquiring and revitalizing well-recognized legacy brands through targeted marketing, product innovation, and a low-cost operating model. Its value proposition centers on maintaining dominant market positions in niche healthcare categories across diverse retail and e-commerce channels.

Competitive position

A market leader in niche OTC categories, with over 60% of revenue derived from brands holding the number one market share position in their respective segments.

GeographiesUnited States, Canada, Australia

Customer segmentsRetailers, Wholesalers, End Consumers

Business modelBrand Management, Asset-light Manufacturing, B2B2C

SuppliersThird-party contract manufacturers, Raw material suppliers, Packaging providers

CustomersMass merchandisers, Drug store chains, Grocery stores, E-commerce retailers

CountryUnited States of America

Listed2005

Employees570.0

CEORonald Lombardi

SectorHealthcare

IndustryMedical - Distribution

Websiteprestigebrands.com

FilingsSEC EDGAR

Ask your AI about Prestige Consumer Healthcare.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prestige Consumer Healthcare's market cap?: Prestige Consumer Healthcare (PBH) has a market capitalization of $2.4B and trades on NYSE.
What is Prestige Consumer Healthcare's revenue and profitability?: Prestige Consumer Healthcare generated $1.1B in trailing twelve-month revenue with net income of $190.3M, representing a net margin of 17.5%. Gross margin stands at 54.7%, with free cash flow of $246.4M. These figures are based on the Q1 2026 filing.
Who are Prestige Consumer Healthcare's competitors?: Prestige Consumer Healthcare's key competitors include Perrigo Company, Procter & Gamble, Johnson & Johnson, and others. These companies compete in similar markets and product categories.
Who does Prestige Consumer Healthcare partner with?: Prestige Consumer Healthcare's notable partners include Information Resources, Inc., Amazon, Walmart.
Where is Prestige Consumer Healthcare headquartered?: Prestige Consumer Healthcare is headquartered in United States of America and employs approximately 570 people. It has been publicly traded since 2005.